Functional Genomics Irbm Irbm’s functional genomics platform empowers biotech and pharmaceutical companies to make confident, data driven decisions in early stage drug discovery. Irbm's functional genomics platform is part of a broader, fully integrated drug discovery ecosystem, ensuring that genetic insights translate into meaningful preclinical models and drug.
Irbm Expands Functional Genomics Platform To Strengthen Early Drug Irbm, a cro specialising in preclinical drug discovery, has expanded its functional genomics platform to support genetic target identification, validation and generation of disease relevant cellular models. By combining functional genomics with expertise in medicinal chemistry, biomarker discovery, and preclinical pharmacology, irbm enables biopharma innovators to approach target validation with greater confidence. Irbm, an integrated contract research organization (cro) specializing in preclinical drug discovery, has established a comprehensive functional genomics platform to support genetic target identification and validation, and generation of disease relevant cellular models. Irbm has unveiled its advanced functional genomics platform, aimed at revolutionizing early drug discovery by improving genetic target validation and modeling.
Functional Genomics Services Drug Discovery Solutions Irbm Irbm, an integrated contract research organization (cro) specializing in preclinical drug discovery, has established a comprehensive functional genomics platform to support genetic target identification and validation, and generation of disease relevant cellular models. Irbm has unveiled its advanced functional genomics platform, aimed at revolutionizing early drug discovery by improving genetic target validation and modeling. By combining functional genomics with expertise in medicinal chemistry, biomarker discovery, and preclinical pharmacology, irbm enables biopharma innovators to approach target validation with greater confidence. Irbm s.p.a. via pontina km 30, 600 00071 pomezia (rm) italy vat n. 10482601001 contact tel. 39 06 91093692 fax 39 06 91093654 info@irbm. Irbm's functional genomics platform is part of a broader, fully integrated drug discovery ecosystem, ensuring that genetic insights translate into meaningful preclinical models and drug development strategies. Irbm, an integrated contract research organization (cro) specializing in preclinical drug discovery, has established a comprehensive functional genomics platform to support genetic target identification and validation, and generation of disease relevant cellular models.
Comments are closed.